13,747
Participants
Start Date
September 1, 2019
Primary Completion Date
January 31, 2021
Study Completion Date
January 31, 2021
Rapid diagnostic test (RDT); Serological and molecular tests on DBS
"The population of low to zero prevalence HAT foci will be actively screened for HAT by taking a blood sample for performing 3 rapid diagnostic tests (RDT) and for preparing dried blood spots to perform 4 serological and molecular high throughput reference tests. If at least one of the RDTs, serological or molecular reference tests is positive, parasitological examination is performed twice. The combined results of parasitological examinations serve as reference standard.~Other Names:~rHAT Sero-Strip (Coris Bioconcept, Belgium) SD Bioline HAT 1.0 (Standard Diagnostics Korea) HAT Sero-K-Set (Coris Bioconcept, Belgium) Immune trypanolysis: presence of antibodies ELISA: on native LiTat 1.3 + LiTat 1.5 variant surface glycoprotein (VSG) LAMP T. brucei Detection Kit (Eiken) RT-PCR: Trypanozoon 18S, Tbg Trypanosoma gambiense specific glycoprotein (TgsGP)"
CIRDES, Bobo-Dioulasso
Institut Pierre Richet, Institut National de Santé Publique, Bouaké
Programme Nationale de Lutte contre la trypanosomiase humaine Africaine, Kinshasa
Ministry of Public Health, Democratic Republic of the Congo
OTHER_GOV
Institut National de Sante Publique
OTHER
CIRDES
UNKNOWN
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
OTHER
Institute of Tropical Medicine, Belgium
OTHER
University of Liverpool
OTHER
Institut de Recherche pour le Developpement
OTHER_GOV